Dutch-based TRXmeds raises funds to further develop its pharma intelligence platform

Utrecht-based TRXmeds, a pharma tech startup that helps businesses grow, announced that it has secured fresh funding in its first investment round to boost the development of its pharmaceutical ecosystem.

The investors in this round remain undisclosed. TRXmeds founder Wâtse Hiddema says, “There is a good vibe and the investor brings a lot of knowledge and experience from the pharmaceutical sector. This gives confidence in a successful collaboration.”

What does TRXmeds offer?

Founded in 2023 by Wâtse Hiddema and Wouter Gruijters, TRXmeds employs a data-driven approach to optimise the pharmaceutical value chain, reducing costs, minimising waste, lowering CO2 emissions, and improving medicine availability for end users.

The platform connects all processes, enabling users to leverage real-time data for informed decision-making and streamlined operations.

Founder Hiddema says, “In a sector that is critical for our health, we believe that transparency, sustainability and efficiency are not an opportunity, but a necessity.”

“With TRXmeds, we are bringing a future-proof ecosystem to the market that is transforming the pharmaceutical industry and guiding sustainable healthcare for all.”

The company claims to have made strides in platform development since Q4 2023, with ongoing discussions with potential customers and strategic partnerships. 

Starting in the Netherlands, TRXmeds aims to expand across Europe, welcoming its first paying customers in March.

Hiddema adds, “With TRXmeds, we are not only building a more efficient pharmaceutical industry, but we are also building a healthier world. And that mission starts now. It’s time to say goodbye to the status quo. It is time for action.”

Brief about the founders

Wâtse Hiddema, CEO and founder of TRXmeds, brings over 12 years of experience in the pharmaceutical and healthcare sector. 

With a focus on improving healthcare through strategic commercial activities, structured innovation, and operational excellence, Hiddema has held management roles in procurement, sales, and business development. He holds a degree in Pharmacy from the University of Groningen.

Wouter Gruijters, COO and founder of TRXmeds, possesses 13 years of experience optimising marketing and sales processes for various (international) companies, emphasising long-term online business success.

Gruijters holds degrees in Marketing Management from Erasmus University Rotterdam and has completed an AI for business graduate programme at INSEAD Business School.